Form 8-K - Current report:
SEC Accession No. 0001680367-24-000012
Filing Date
2024-02-29
Accepted
2024-02-29 16:07:14
Documents
15
Period of Report
2024-02-29
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K sttk-20240229.htm   iXBRL 8-K 29186
2 EX-99.1 sttk_ye2023earningsrelease.htm EX-99.1 98717
  Complete submission text file 0001680367-24-000012.txt   273736

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sttk-20240229.xsd EX-101.SCH 1916
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sttk-20240229_lab.xml EX-101.LAB 25850
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sttk-20240229_pre.xml EX-101.PRE 13591
16 EXTRACTED XBRL INSTANCE DOCUMENT sttk-20240229_htm.xml XML 2911
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39593 | Film No.: 24703615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)